[BioTech Industry] Local Vaccine Manufacturer to Be Listed on Stock Market

[BioTech Industry] Local Vaccine Manufacturer to Be Listed on Stock Market (Chinese Version)

CNA – Focus Taiwan (2012/02/06) Adimmune Corp., a local vaccine manufacturer in Central Taiwan, could be listed on the stock market in March at the earliest, a company official said February 6.

Adimmune Chairman Chi-shean CHAN made the remarks after the Taiwan Stock Exchange Corp. (TWSE) approved its application.

The company also announced several steps forward in its business, including the completion of clinical testing of influenza vaccine in Europe with Netherlands-based Crucell, with which Adimmune has an alliance.

The H5N1 vaccine, which completed animal testing late last year, is scheduled to go into human testing in the second quarter this year at the earliest.

In addition, the company's cell culture plant in the Central Taiwan Science Park (CTSP) is expected to complete construction in 2014 and to start production in 2015.


Further Information:
CNA – Focus Taiwan 2012/02/06